Selective BRM inhibitor and degrader therapy(Loxo Oncology at Lilly/Foghorn Therapeutics)
N/A
Report date: 2023/12/18 14:02:15
Base Information
Drug NameSelective BRM inhibitor and degrader therapy(Loxo Oncology at Lilly/Foghorn Therapeutics)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLoxo Oncology IncFoghorn Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesLoxo Oncology IncFoghorn Therapeutics Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A